Evaluation of indibulin, a novel tubulin targeting-agent, in combination with capecitabine, with mathematically optimized dose scheduling
Year: 2009
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: J. J. Lewis, M. D. Galsky, L. H. Camacho, D. M. Loesch, P. B. Komarnitsky, L. Norton
Institution: Comprehensive Cancer Centers of Nevada
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2244538381
